Coronary heart disease post-PCI with comorbid somatization disorder
Conditions
Interventions
Experimental group:Oral Anshen Buxin Paste
Control group:Anshen Buxin Paste Placebo Oral
Sponsors
Changshu Municipal Hospital of Traditional Chinese Medicine (Changshu New District Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Meets the above diagnostic criteria of Western medicine and Traditional Chinese Medicine, aged over 18 years and under 85 years; 2) The patient is conscious and able to answer questions independently and clearly; 3) Signed the informed consent form and agreed to participate in this follow-up treatment observation.
Exclusion criteria
Exclusion criteria: 1) Exclude patients with severe physical illnesses, such as tumors or severe liver and kidney dysfunction; 2) Exclude patients with severe somatization disorder, severe anxiety or depression, or those with other mental disorders, suicidal tendencies, or abuse and dependence on psychiatric medications; 3) Exclude pregnant or breastfeeding women; 4) Exclude those who are allergic or intolerant to components of traditional Chinese medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of somatization disorder; | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of anxiety;Severity of depression;Sleep condition;Traditional Chinese Medicine Syndrome Scoring;Heart rate variability measurement; | — |
Countries
China
Contacts
Public ContactYaozhong Zhou
Changshu Municipal Hospital of Traditional Chinese Medicine (Changshu New District Hospital)
Outcome results
None listed